For instance, inhibiting AKR1C3, an enzyme involved in converting DHEA-S into the potent AR ligands testosterone and dihydrotestosterone (DHT), has been shown to inhibit prostate cancer cell growth in cell culture and xenograft models [43, 44]. The gene discussed is AKR1C3; the disease is prostate carcinoma.